Summit Therapeutics Inc. — Investor Relations & Filings
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapies for serious unmet medical needs, with a primary focus on oncology. The company's mission is to improve the quality and potential duration of life for patients. Its lead product candidate is ivonescimab (SMT112), a novel bispecific antibody that targets both PD-1 and VEGF. Summit is advancing ivonescimab through multiple global Phase III clinical trials to treat various solid tumors, with a significant emphasis on non-small cell lung cancer (NSCLC). The company's strategy centers on developing innovative treatments that can provide substantial benefits for patients, physicians, and caregivers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Summit Therapeutics Inc. (0001599298) (Filer) | 2026-04-30 | English | |
| DEF 14A - Summit Therapeutics Inc. (0001599298) (Filer) | 2026-04-17 | English | |
| 10-K - SUMMIT THERAPEUTICS INC. (0001599298) (Filer) | 2026-02-23 | English | |
| 8-K - SUMMIT THERAPEUTICS INC. (0001599298) (Filer) | 2026-02-23 | English | |
| 8-K Filing | 2026-01-29 | English | |
| FORM 4 | 2026-01-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39226506 | 10-Q - Summit Therapeutics Inc. (0001599298) (Filer) | 2026-04-30 | English | ||
| 34662077 | DEF 14A - Summit Therapeutics Inc. (0001599298) (Filer) | 2026-04-17 | English | ||
| 32894822 | 10-K - SUMMIT THERAPEUTICS INC. (0001599298) (Filer) | 2026-02-23 | English | ||
| 32894821 | 8-K - SUMMIT THERAPEUTICS INC. (0001599298) (Filer) | 2026-02-23 | English | ||
| 30827049 | 8-K Filing | 2026-01-29 | English | ||
| 12749857 | FORM 4 | 2026-01-12 | English | ||
| 12749858 | 8-K | 2026-01-12 | English | ||
| 12749859 | FORM 4 | 2026-01-07 | English | ||
| 12749860 | FORM 4 | 2026-01-07 | English | ||
| 12749861 | FORM 4 | 2026-01-07 | English | ||
| 12749862 | FORM 4 | 2026-01-07 | English | ||
| 12749863 | FORM 4 | 2026-01-07 | English | ||
| 12749864 | FORM 4 | 2026-01-07 | English | ||
| 12749865 | FORM 4 | 2026-01-07 | English | ||
| 12749866 | FORM 4 | 2026-01-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
Summit Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30436/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30436 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30436 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30436 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30436}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Summit Therapeutics Inc. (id: 30436)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.